Company
Technology
Partnership
Media
- Events & Presentations
- Publications
Careers
Contact Us

Featured speaker at the Cell Therapy Manufacturing Asia meeting in Kyoto

Share the opportunities and challenges of CAR-T in Taipei

Non-viral CAR-T therapy presentation in Taipei.

Our Chief Strategy & Process Development Officer, Karen Wen, Ph.D....

Our Chief Strategy & Process Development Officer, Karen Wen, Ph.D., presented our promising research in non-viral CAR-T therapy in “The Advanced Immuno-Oncology Forum” in Taipei on November 20, 2019.

Share

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.

Type in the text displayed above

Company

Our Mission
Leadership
Pipeline
Partnership

Our Technology

GTailor
Quantum Nufect
Quantum pBac
iCellar
qCART
Protein / Target Hunter

Media

Events & Presentation
Publication

Careers

Contact Us

Terms and Conditions

© 2023 GenomeFrontier Therapeutics, Inc. All Rights Reserved.